Clinical Trials Update: Feb. 23, 2011

GoutArthritis and Cardiovascular DiseaseAdvanced Parkinson's Disease

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Gout

This study will evaluate the cardiovascular safety of an investigational drug combined with allopurinol in people with gout and cardiovascular problems. You must be 50 or older and have a uric acid level greater than 6.0 percent to qualify.

The research site is in San Antonio, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Arthritis and Cardiovascular Disease

This study will compare celecoxib (Celebrex) to NSAIDs (Ibuprofen, Naproxen) in people with osteoarthritis or rheumatoid arthritis and risk factors for, or a history of, cardiovascular disease.

The research site is in Mesa, Ariz.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.

-----

Advanced Parkinson's Disease

This study will evaluate an investigational drug to treat certain side effects caused by levodopa (L-dopa) in people with advanced Parkinson's.

The research site is in Milwaukee, Wisc.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/parkinson's_disease.aspx.

-----

Copyright 2011 ClinicalConnection.com. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com